- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02503098
Optimizing a Smartphone Application for Individuals With Eating Disorders
Study Overview
Status
Conditions
Detailed Description
Eating Disorders (ED) are common and serious psychological disorders. Anorexia Nervosa (AN) has a prevalence estimated at between 0.48% and 0.70% among young females. Bulimia Nervosa (BN) is a serious mental health problem, with a prevalence of between 1-2% of young women while clinically significant bulimic behaviors occur in an additional 2-3%. There are significant barriers to access of evidence-based treatments and current models of individual psychotherapy will likely never meet the enormous need for psychological services for ED. Unfortunately, even with treatment, rates of recovery are modest with the best performing treatments achieving remission in only about 50% of cases while relapse rates are high, especially if the ED becomes chronic. It is widely acknowledged that a major shift in intervention practice is needed and that smartphone apps will almost certainly play a role due to their reach and breadth of functionality.
As the first commercially available smartphone app for EDs, Recovery Record (RR) has established wide reach and user acceptability. The app provides users with meal and ED symptom self-monitoring and coping skill strategies in an evidence-based CBT format. Preliminary pilot data suggest that for a proportion of RR users, using RR is associated with clinically significant symptom reduction. However, a limitation of the current app is that it is a "one-size-fits-all" product that does not account for the heterogeneity of ED symptoms. Genetic, personality and neurocognitive data support distinct clusters of ED presentations that also differ according to response to treatment, course and outcome. Pilot data confirm that clinical response to RR is not homogenous across groups and that extent of cognitive distortions is the most potent factor to predict outcome. There is considerable opportunity to increase RR's effectiveness across a range of ED symptoms and behaviors by creating adaptive and tailored content focused on remediation of cognitive distortions.
During Phase 1 of this study screening algorithm will be validated against an unseen, prospective test dataset of approximately 2,000 users. All candidate predictor variables will be entered into a Signal Detection Analysis to confirm the sensitivity and specificity of the screen. Informed by the resultant algorithms, adaptive content will be developed that targets ED-specific cognitive distortions. To evaluate acceptability, adapted content will be piloted with approximately 200 individuals for a period of one month. Participant feedback and utilization data will inform content acceptability and feasibility. By the end of the first phase tailored content that is acceptable to individuals with specific symptom presentations will be developed.
Phase 2 will focus on an evaluation of whether an adaptive app offering tailored content addressing eating related cognitive distortions in a stepped way can outperform the current standard app. The adaptive content will be integrated into a new, dynamic version of the app (RR-A) that will then be evaluated against the current app (RR-S). Approximately 5,000 registered users of RR will be randomized to receive either RR augmented with targeted content (RR-A), or RR in its current standard format (RR-S) over a two-month period. Outcome data will be measured at baseline, one month, end of treatment, and at six-month follow-up. At the end of the study period it is predicted that the resultant evidence-based product will have demonstrated ability to bring about clinically significant reduction in symptoms in more users than the current app, and thus will have potential to make a substantial public health impact.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
San Francisco, California, United States, 94107
- Recovery Record Research
-
Stanford, California, United States, 94304
- Stanford University School of Medicine, Department of Psychiatry and Behavioral Sciences
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Meets criteria for clinically significant symptoms of eating disorder using self-report measures
- Has an Android or iPhone and is willing to use phone for the study
- Is able to speak and read English
- Lives within the United States of America
- Is at least 16 years of age
Exclusion Criteria:
- Has visual, hearing, voice, or motor impairment that would prevent completion of study and treatment procedures
- Has any psychiatric condition for which participation in a clinical trial of psychotherapy may be either inappropriate or dangerous (e.g., psychotic disorders, bipolar disorders, severe post traumatic stress disorder, etc.).
- Exhibits severe suicidality, including ideation, plan, and intent.
- Currently receiving weekly psychotherapy or planning to receive weekly psychotherapy for eating disorder during the 12 weeks of the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Recovery Record adaptive smartphone application (RR-A)
Participants will have access to all Recovery Record standard functions and will additionally receive tailored, algorithm-generated content targeting cognitive distortions.
|
|
|
Active Comparator: Recovery Record standard smartphone application (RR-S)
Participants will have access to all Recovery Record standard functions, including meal monitoring, motivational enhancement, social support, and coping skill strategies.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in Eating Disorder Severity
Time Frame: Measured at the start of treatment (baseline), week 4, week 8 and 6 months follow-up
|
Self-reported eating disorder symptom severity.
To measure changes in eating disorder severity over time, the Eating Disorder Evaluation Questionnaire (EDE-Q) will be used.
|
Measured at the start of treatment (baseline), week 4, week 8 and 6 months follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Binge eating and purging episode frequency
Time Frame: Measured at the start of treatment (baseline), week 4, week 8 and 6 months follow-up
|
Self-reported disordered behavior frequency will be assessed via behaviors self-monitored in the application in addition to symptom frequency questions in the Eating Disorder Evaluation Questionnaire.
|
Measured at the start of treatment (baseline), week 4, week 8 and 6 months follow-up
|
|
Changes in Clinical Impairment Severity
Time Frame: Measured at the start of treatment (baseline), week 4, week 8 and 6 months follow-up
|
To measure changes in eating disorder related clinical impairment over time, the self-reported Clinical Impairment Assessment (CIA) will be used.
|
Measured at the start of treatment (baseline), week 4, week 8 and 6 months follow-up
|
|
Participant Satisfaction
Time Frame: Participants will be followed for the duration of the 8-week trial
|
Self-reported satisfaction
|
Participants will be followed for the duration of the 8-week trial
|
|
Adherence to the mobile application intervention
Time Frame: Measured from the start of application utilization (baseline) to 8-weeks
|
Adherence will be measured via dichotomous outcome of drop-out (an individual will be considered a system drop-out if they fail to login to the app at all for a period of 14 consecutive days).
Adherence will be assessed through application usage data.
|
Measured from the start of application utilization (baseline) to 8-weeks
|
|
Adherence to self-monitoring tasks
Time Frame: Measured from the start of application utilization (baseline) to 8-weeks
|
Frequency of self-monitoring entries will be tracked automatically through the program server.
|
Measured from the start of application utilization (baseline) to 8-weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- RRR-023
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bulimia Nervosa
-
University of California, San DiegoActive, not recruitingAnorexia Nervosa | Bulimia Nervosa | Atypical Anorexia Nervosa | Atypical Bulimia NervosaUnited States
-
Istituto Auxologico ItalianoCatholic University of the Sacred Heart; University of Turin, Italy; Open University and other collaboratorsRecruitingAnorexia Nervosa/BulimiaItaly
-
University Hospital, ToulouseUnknownAnorexia Nervosa/BulimiaFrance
-
Maastricht UniversityZonMw: The Netherlands Organisation for Health Research and Development; Utrecht... and other collaboratorsRecruitingAnorexia Nervosa | Bulimia Nervosa | Atypical Anorexia Nervosa (Other Specified Eating Disorder) | Atypical Bulimia Nervosa (Other Specified Eating Disorder)Netherlands
-
University of California, San DiegoRecruitingAnorexia Nervosa | Bulimia NervosaUnited States
-
University of California, San DiegoRecruitingAnorexia Nervosa | Bulimia NervosaUnited States
-
Washington University School of MedicineNational Institute of Mental Health (NIMH)Completed
-
Rosemary Claire RodenChildren's Miracle NetworkTerminatedBulimia Nervosa | Impulsive Behavior | Purging (Eating Disorders) | Eating Disorders | Eating Disorders in Adolescence | Anorexia Nervosa/Bulimia | Anorexia in Adolescence | Anorexia Nervosa, Atypical | Anorexia Nervosa, Binge Eating/Purging TypeUnited States
-
Yeshiva UniversityYale UniversityCompletedAnorexia Nervosa | Bulimia Nervosa | Anorexia Nervosa, Atypical | Bulimia; AtypicalUnited States
-
Centre Hospitalier EsquirolNot yet recruitingAnorexia Nervosa | Hyperphagia | Eating Disorders | Boulimia NervosaFrance
Clinical Trials on Recovery Record adaptive smartphone application
-
Nova Scotia Health AuthorityWithdrawnBulimia Nervosa | Eating Disorder | Binge Eating DisorderCanada
-
Sheba Medical CenterWithdrawnB.E.D AND BULIMIA PATIENT | SMARTPHONE OWNER | BASIC ENGLISH SPEAKERIsrael
-
Dartmouth-Hitchcock Medical CenterPatient-Centered Outcomes Research InstituteCompletedSchizophrenia | Schizoaffective Disorder | Bipolar Disorder | Major Depressive DisorderUnited States
-
Nova Scotia Health AuthorityCompletedEating DisordersCanada
-
Ohio State University Comprehensive Cancer CenterRecruitingPancreatic AdenocarcinomaUnited States
-
Jordan University of Science and TechnologyCompletedUrinary IncontinenceJordan
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH); University of Utah; uBiome; Recovery...CompletedBinge-Eating Disorder | Bulimia NervosaUnited States
-
Kibi International UniversityCompleted
-
University Hospital, MontpellierCompleted
-
Gunma UniversityCompletedSubthreshold DepressionJapan